Related Experiment Video
Updated: Feb 24, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages
Stefano Bonelli1,2, Xenia Geeraerts1,2, Evangelia Bolli1,2
1Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
Abstract:
Tumor-associated macrophages (TAM) are by now established as important regulators of tumor progression by impacting on tumor immunity, angiogenesis, and metastasis. Hence, a multitude of approaches are currently pursued to intervene with TAM's protumor activities, the most advanced of which being a blockade of macrophage-colony stimulating factor (M-CSF)/M-CSF receptor (M-CSFR) signaling. M-CSFR signaling largely impacts on the differentiation of macrophages, including TAM, and hence strongly influences the numbers of these cells in tumors. However, a repolarization of TAM toward a more antitumor phenotype may be more elegant and may yield stronger effects on tumor growth. In this respect, several aspects of TAM behavior could be altered, such as their intratumoral localization, metabolism and regulatory pathways. Intervention strategies could include the use of small molecules but also new generations of biologicals which may complement the current success of immune checkpoint blockers. This review highlights current work on the search for new therapeutic targets in TAM.
Insights
Tumor-associated macrophages (TAM) drive tumor progression. Targeting their repolarization, rather than just numbers via M-CSF/M-CSFR blockade, may offer superior anti-tumor effects.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Tumor-associated macrophages (TAM) are key regulators of tumor progression.
- TAM influence tumor immunity, angiogenesis, and metastasis.
- Current strategies focus on blocking M-CSF/M-CSFR signaling to reduce TAM numbers.
Purpose of the Study:
- To review current research on therapeutic targets within TAM.
- To explore strategies beyond M-CSF/M-CSFR blockade for anti-TAM therapies.
- To highlight novel approaches for repolarizing TAM towards an anti-tumor phenotype.
Main Methods:
- Literature review of current research on TAM.
- Analysis of therapeutic strategies targeting TAM.
- Discussion of novel intervention approaches including small molecules and biologics.
Main Results:
- TAM play a critical role in tumor progression.
- Blocking M-CSF/M-CSFR signaling impacts TAM numbers.
- Repolarizing TAM offers a promising alternative therapeutic strategy.
- Altering TAM localization, metabolism, and regulatory pathways are potential targets.
Conclusions:
- Targeting TAM is a crucial area in cancer therapy.
- Repolarizing TAM may be more effective than reducing their numbers.
- New therapeutic strategies, including biologics, are emerging to complement existing treatments.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy

